glp-1-based weight-loss drugs The FDA has approved the first GLP-1 pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular Professor Receives Grant to Study

Its puzzling, is it not

All the data presented here were anonymously analyzed and reported

Highlights Shorter reporting timelines for posting study results on ClinicalTrials.gov

Things Worth Researching Further If you want to go deeper: The 2025 Al-dulaimi independent replication paper first non-Khavinson-group confirmation of the core telomerase mechanism

The brain-gut axis in irritable bowel syndrome--clinical aspects

The reasons are familiar: No pharmaceutical patents mean no marketing budgets Medical education focuses on drugs, not peptides Insurance doesnt cover investigational treatments Regulatory complexity around peptide therapies Meanwhile, patients continue to suffer with immune dysfunction that could potentially be addressed with these well-researched tools